Change of Auditor

RNS Number : 4704V
Dr. Martens PLC
13 December 2021
 

13th December 2021

 

Dr. Martens plc

(the "Company")

 

Change of Auditor

 

The Company announces its intention to appoint Pricewaterhouse Coopers LLP as its auditor for the financial year ending 31 March 2023 subject to approval by the Company's shareholders at the next Annual General Meeting to be held in 2022.

 

The selection of Pricewaterhouse Coopers LLP was approved by the Board following an extensive competitive tender process overseen by the Audit and Risk Committee. Ernst & Young LLP (EY), the Company's current external auditor, will continue to undertake the audit for the financial year ending 31 March 2022 and will step down on completion of that audit.

 

The Board wishes to extend its appreciation and gratitude to EY for its services rendered to the Company throughout its tenure.

 

Enquiries:

 

Investors and analysts

Bethany Barnes, Director of Investor Relations

+44 7825 187465

bethany.barnes@drmartens.com

 

About Dr. Martens plc:

 

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company successfully listed on the main market of the London Stock Exchange in January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFFFFDDEFSEDE

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings